Biostatistics

Biostatistics - Axcellant

Biostatistics

  1. lut 28, 2025

What Does 'Biostatistics’ Mean?

Biostatistics refers to the application of statistical methods to biological data and problems in the life sciences. It involves the design of biological experiments, especially in medicine and agriculture, as well as the collection, analysis, and interpretation of data from those experiments.

This field combines principles from statistics, mathematics, and computer science to address questions in public health, medicine, and biology. Biostatisticians play a crucial role in clinical trials, epidemiological studies, and genomic research by ensuring the validity and reliability of scientific conclusions drawn from complex biological datasets.

Why Is the 'Biostatistics’ Important in Clinical Research?

Biostatistics is crucial in clinical research as it provides the methodological framework for designing studies, analyzing data, and interpreting results. It ensures that clinical trials are conducted with scientific rigor, minimizing bias and maximizing the reliability of findings that can impact patient care and medical knowledge.

The application of biostatistics in clinical research helps researchers determine appropriate sample sizes, assess the significance of treatment effects, and account for confounding variables. This statistical expertise is essential for regulatory approval of new drugs and medical devices, as well as for the development of evidence-based clinical guidelines and public health policies.

Good Practices and Procedures

  1. Implement blinding techniques in study design to reduce bias and enhance objectivity in data collection and analysis
  2. Conduct power analyses prior to study initiation to determine optimal sample sizes for detecting clinically meaningful effects
  3. Utilize mixed-effects models to account for both fixed and random effects in longitudinal studies
  4. Employ multiple imputation methods to handle missing data, preserving statistical power and reducing bias
  5. Perform sensitivity analyses to assess the robustness of results under different assumptions or analytical approaches

Related Terms

Read more

How clinical trials can become a strategic asset for biotech startups

Clinical trials are often seen as a regulatory necessity, but for biotech and medtech startups, they can be much more.…

Advancing PET Innovation at SNMMI 2025

Axcellant participated in SNMMI’s 2025 Annual Meeting in New Orleans, where nearly 8,000 professionals in nuclear medicine and molecular imaging gathered…

Insights from Turku PET Symposium 2025

Axcellant participated in the PET Symposium 2025, held in Turku, marking 50 years of PET radiochemistry at the Turku PET…